Aylin S. Ulku, Ph.D. - Publications

Affiliations: 
2003 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Molecular Biology, Pharmacology, Cell Biology, Oncology

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Campbell PM, Singh A, Williams FJ, Frantz K, Ulkü AS, Kelley GG, Der CJ. Genetic and pharmacologic dissection of Ras effector utilization in oncogenesis. Methods in Enzymology. 407: 195-217. PMID 16757325 DOI: 10.1016/S0076-6879(05)07017-5  0.73
2006 Booden MA, Ulku AS, Der CJ. Cellular assays of oncogene transformation Cell Biology, Four-Volume Set. 1: 345-352. DOI: 10.1016/B978-012164730-8/50042-3  0.56
2005 Pruitt K, Ulkü AS, Frantz K, Rojas RJ, Muniz-Medina VM, Rangnekar VM, Der CJ, Shields JM. Ras-mediated loss of the pro-apoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells. The Journal of Biological Chemistry. 280: 23363-70. PMID 15831492 DOI: 10.1074/Jbc.M503083200  0.666
2004 Collette J, Ulku AS, Der CJ, Jones A, Erickson AH. Enhanced cathepsin L expression is mediated by different Ras effector pathways in fibroblasts and epithelial cells. International Journal of Cancer. Journal International Du Cancer. 112: 190-9. PMID 15352030 DOI: 10.1002/Ijc.20398  0.76
2004 Eckert LB, Repasky GA, Ulkü AS, McFall A, Zhou H, Sartor CI, Der CJ. Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis. Cancer Research. 64: 4585-92. PMID 15231670 DOI: 10.1158/0008-5472.Can-04-0396  0.728
2003 Ulkü AS, Schäfer R, Der CJ. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells. Molecular Cancer Research : McR. 1: 1077-88. PMID 14707291  0.69
2003 Vos MD, Ellis CA, Elam C, Ulku AS, Taylor BJ, Clark GJ. RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor. The Journal of Biological Chemistry. 278: 28045-51. PMID 12732644 DOI: 10.1074/Jbc.M300554200  0.706
2003 Ulkü AS, Der CJ. Ras signaling, deregulation of gene expression and oncogenesis. Cancer Treatment and Research. 115: 189-208. PMID 12613198 DOI: 10.1007/0-306-48158-8_8  0.751
2001 McFall A, Ulkü A, Lambert QT, Kusa A, Rogers-Graham K, Der CJ. Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase. Molecular and Cellular Biology. 21: 5488-99. PMID 11463831 DOI: 10.1128/Mcb.21.16.5488-5499.2001  0.775
2001 Fiordalisi JJ, Johnson RL, Ulkü AS, Der CJ, Cox AD. Mammalian expression vectors for Ras family proteins: generation and use of expression constructs to analyze Ras family function. Methods in Enzymology. 332: 3-36. PMID 11305105 DOI: 10.1016/S0076-6879(01)32189-4  0.668
Show low-probability matches.